A New Access to the 6,8-Dioxabicyclo[3.2.1]octane Ring System Using a Three-Component Reaction: Enantioselective Synthesis of (+)-iso-exo-Brevicomin

Abstract

The combination of a catalytic hetero-Diels-Alder-­allylboration sequence and a ruthenium-catalyzed isomerization of an allylic alcohol moiety as key steps open a new route for the asymmetric synthesis of 6,8-dioxabicyclo[3.2.1]octane subunits. The application of this strategy to the synthesis of (+)-iso-exo-brevi­comin is also reported.

Key words

natural product - asymmetric catalysis - cycloaddition - boron - redox isomerization

References and Notes

• 1a Mori K. Tetrahedron  1989,  45:  3233 
• 1b Francke W. Schröder W. Curr. Org. Chem.  1999,  3:  407 
• Some examples:
• 2a For palytoxin, see: Moore RE. Prog. Chem. Org. Nat. Prod.  1985,  48:  81 
• 2b For pinnatoxin A, see: Uemura D. Chou T. Haino T. Nagatsu A. Fukuzawa S. Zheng SZ. Chen HS. J. Am. Chem. Soc.  1995,  117:  1155 
• 2c For attenol A, see: Takada N. Suenaga K. Yamada K. Zheng S.-Z. Chen H.-S. Uemura D. Chem. Lett.  1999,  1025 
• 2d For pteriatoxins, see: Takada N. Umemura N. Suenaga K. Uemura D. Tetrahedron Lett.  2001,  42:  3495 
• 2e For trichodermatide A, see: Sun Y. Tian L. Huang J. Ma H.-Y. Zheng Z. Lv A.-L. Yasukawa K. Pei Y.-H. Org. Lett.  2008,  10:  393 
• 3 Mitchell SS. Rhodes D. Bushman FD. Faulkner DJ. Org. Lett.  2000,  2:  1605 
• 4a Milroy L.-G. Zintalla G. Prencipe G. Michel P. Ley S. Gunaratnam M. Beltran M. Neidle S. Angew. Chem. Int. Ed.  2007,  46:  2493 
• 4b Milroy L.-G. Zintalla G. Loiseau F. Qian Z. Prencipe G. Pepper C. Fegan C. Ley SV. ChemMedChem  2008,  3:  1922 
• 5a Burke SD. Müller N. Beaudry CM. Org. Lett.  1999,  1:  1827 
• 5b Marvin CC. Voight EA. Suh JM. Paradise CL. Burke SD. J. Org. Chem.  2008,  73:  8452 
• For the formation of dioxabicyclo[3.2.1]octane structure via catalyzed cycloisomerization, see:
• 6a Antoniotti S. Genin E. Michelet V. Genet JP. J. Am. Chem. Soc.  2005,  127:  9976 
• 6b Liu B. De Brabander JK. Org. Lett.  2006,  8:  4907 
• 6c Ramana CV. Patel P. Gonnade RG. Tetrahedron Lett.  2007,  48:  4771 
• 6d Diéguez-Vasquez A. Tzschuscke CC. Lam WY. Ley SV. Angew. Chem. Int. Ed.  2008,  47:  209 
• 6e Ramana CV. Induvadana B. Tetrahedron Lett.  2009,  50:  271 
• For some reviews on synthesis of bridged bicyclic ketals, see:
• 7a Kotsuki H. Synlett  1992,  97 
• 7b Kiyota H. Top. Heterocycl. Chem.  2006,  5:  65 
• 8 Gademan K. Chavez DE. Jacobsen EN. Angew. Chem. Int. Ed.  2002,  41:  3059 
• 9a Deligny M. Carreaux F. Toupet L. Carboni B. Adv. Synth. Catal.  2003,  345:  1215 
• 9b Gao X. Hall DG. J. Am. Chem. Soc.  2003,  125:  9308 
• 9c Gao X. Hall DG. Deligny M. Favre A. Carreaux F. Carboni B. Chem. Eur. J.  2006,  12:  3132 
• 10a Deligny M. Carreaux F. Carboni B. Synlett  2005,  1462 
• 10b Gao X. Hall DG. J. Am. Chem. Soc.  2005,  127:  1628 
• 10c Carreaux F. Favre A. Carboni B. Rouaud I. Boustie J. Tetrahedron Lett.  2006,  47:  4545 
• 10d Favre A. Carreaux F. Deligny M. Carboni B. Eur. J. Org. Chem.  2008,  4900 
• 10e Penner M. Rauniyar V. Kaspar LT. Hall DG. J. Am. Chem. Soc.  2009,  131:  14216 
• 13 Francke W. Schröder F. Philipp P. Meyer H. Sinnwell V. Gries G. Bioorg. Med. Chem.  1996,  4:  363 
• 14a Mori K. Takikawa H. Nishimura Y. Horikiri H. Liebigs Ann./Recl.  1997,  327 
• 14b Taniguchi T. Takeuchi M. Ogasawara K. Tetrahedron: Asymmetry  1998,  9:  1451 
• 14c De Sousa AL. Resck IS. J. Braz. Chem. Soc.  2002,  13:  233 
• 14d Prasad KR. Anbarasan P. Tetrahedron: Asymmetry  2007,  18:  1419 
• 16a Using isomerization of allylic alcohols, see: Ito M. Kitahara S. Ikariya T. J. Am. Chem. Soc.  2005,  127:  6172 
• 16b Using isomerization of propargylic alcohols, see: Trost BM. Livingston RC. J. Am. Chem. Soc.  2008,  130:  11970 
• For reviews, see:
• 17a Uma R. Crévisy C. Grée R. Chem. Rev.  2003,  103:  27 
• 17b Cadierno V. Crochet P. Gimeno J. Synlett  2008,  1105 
• 18 Bouziane A. Carboni B. Bruneau C. Carreaux F. Renaud J.-L. Tetrahedron  2008,  64:  11745 
• 21 Gravel M. Touré BB. Hall DG. Org. Prep. Proced. Int.  2004,  36:  573 

11

General Procedure and Selected Characterization Data
To a stirred solution of 3 (0.3 mmol) in CH₂Cl₂ (3 mL) at 0 ˚C was added BF₃˙OEt₂ (0.33 mmol). After 10 min, the resulting solution was warmed to r.t. and stirred for 90 min (excepted in the case of 3d). The reaction mixture was quenched with sat. aq NaHCO₃ (1 mL), and the aqueous phase was extracted with Et₂O (2 × 2 mL). The combined organic phases were washed with brine, dried over MgSO₄, filtrated, and concentrated under reduced pressure. Compounds 4 were purified by flash chromatography on silica gel (210-400 mesh).
Compound 4d was obtained as a colorless oil (95%). [α]_D ^²5 +33.5 (c 1.75, CH₂Cl₂). ^¹H NMR (300 MHz, CDCl₃): δ = 1.03 (s, 9 H), 1.91-1.97 (m, 1 H), 2.33-2.42 (m, 1 H), 4.26 (d, 1 H, J = 8.4 Hz), 4.44 (d, 1 H, J = 8.8 Hz), 4.47 (d, 1 H, J = 4.9 Hz), 5.50-5.52 (m, 1 H), 5.60-5.63 (m, 1 H), 5.98-6.04 (m, 1 H), 7.20-7.28 (m, 7 H), 7.35-7.49 (m, 6 H), 7.66-7.71 (m, 2 H). ^¹³C NMR (75 MHz, CDCl₃): δ = 19.4, 26.9, 33.8, 72.0, 75.0, 88.7, 100.9, 124.3, 127.4, 127.5, 127.6, 127.7, 128.0, 128.9, 129.7, 129.8, 133.0, 134.0, 135.9, 136.0, 141.4. Anal. Calcd for C₂₉H₃₂O₃Si: C, 76.28; H, 7.06. Found: C, 76.35; H, 7.01.

12

Compound 8 was obtained as colorless oil (87%). [α]_D ^²5 +20.3 (c 1.30, CH₂Cl₂). ^¹H NMR (300 MHz, CDCl₃): δ = 1.03 (s, 9 H), 1.45-1.88 (m, 4 H), 2.29 (br s, 1 H), 3.60-3.63 (m, 1 H), 4.04 (d, 1 H, J = 7.3 Hz), 4.20-4.25 (m, 1 H), 4.49 (d, 1 H, J = 7.3 Hz), 5.32 (br s, 1 H), 7.21-7.33 (m, 7 H), 7.35-7.48 (m, 6 H), 7.61-7.69 (m, 2 H). ^¹³C NMR (75 MHz, CDCl₃): δ = 19.4, 23.8, 26.8, 26.9, 66.7, 76.1, 77.2, 78.9, 81.5, 102.5, 127.4, 127.6, 127.8, 128.1, 129.6, 129.8, 133.1, 133.8, 135.9, 136.0, 140.9. Anal. Calcd for C₂₉H₃₄O₄Si: C, 73.38; H, 7.22. Found: C, 73.37; H, 7.11.

15

The ee was measured by GC analysis using a chiral stationary phase (Varian WCOT Fused Silica 25 × 0.25 mm coated CP Chirasil-dex CB DF = 0.25).

19

1-Phenylpropan-1-one can be obtained from the corresponding allylic alcohol in 97% yield with only 2 mol% of [RuCp*(MeCN)₃][PF₆] in toluene at r.t. These new conditions represent an improvement of the previously described process with this catalyst.

20

Characterization Data for Key Synthetic Intermediates
Compound 3e was obtained from 1 in 70% yield as a colorless oil. [α]_D ^²5 +72 (c 0.59, CH₂Cl₂). ^¹H NMR (300 MHz, CDCl₃): δ = 1.18-1.25 (m, 6 H), 2.19-2.22 (m, 2 H), 2.72 (br s, 1 H), 3.53 (dq, 1 H, J = 7.1, 9.3 Hz), 3.69-3.72 (m, 1 H), 3.96 (dq, 1 H, J = 7.1, 9.3 Hz), 3.98-4.03 (m, 1 H), 4.72 (dd, 1 H, J = 4.8, 6.1 Hz), 5.60-5.63 (m, 1 H), 5.78-5.80 (m, 1 H). ^¹³C NMR (75 MHz, CDCl₃): δ = 15.2, 18.6, 31.1, 64.4, 69.6, 78.8, 98.5, 124.9, 126.1. HRMS (EI): m/z [M -˙OCH₂CH₃]⁺ calcd for C₇H₁₁O₂: 127.0759; found: 127.0755.
Compound 12 was obtained as colorless oil (mixture of diastereomers, 63%). ^¹H NMR (300 MHz, CDCl₃): δ = 1.20 (d, 3 H, J = 5.9 Hz), 1.35-1.70 (m, 6 H), 1.81 (br s, 1 H), 2.68 (br s, 1 H), 3.40-3.43 (m, 2 H), 4.09-4.12 (m, 1 H), 4.43 (d, 1 H, J = 11.5 Hz), 4.68 (d, 1 H, J = 11.5 Hz), 5.11 (dd, 1 H, J = 1.2, 10.4 Hz), 5.23 (d, 1 H, J = 17.2 Hz), 5.88 (ddd, 1 H, J = 6.2, 10.4, 17.2 Hz), 7.26-7.43 (m, 5 H). ^¹³C NMR (75 MHz, CDCl₃): δ = 15.5, 21.3, 21.4, 32.5, 32.6, 36.9, 71.0, 73.0, 73.1, 74.8, 74.9, 78.3, 78.4, 114.5, 114.6, 127.7, 127.8, 128.5, 138.3, 141.1, 141.2. ESI-HRMS: m/z [M + Na]⁺ calcd for C₁₆H₂₄O₃Na: 287.1623; found: 287.1623.
(+)-Iso-exo-brevicomin was obtained as a colorless oil (highly volatile, 60%): [α]_D ^²5 +53 (c 0.3, CHCl₃); lit.^¹4d [α]_D +54 (c 0.5, CHCl₃). ^¹H NMR (300 MHz, CDCl₃): δ = 0.96 (t, 3 H, J = 7.9 Hz), 1.18 (d, 3 H, J = 6.5 Hz), 1.43-1.95 (m, 8 H), 4.06 (br s, 1 H), 4.22 (q, 1 H, J = 6.5 Hz). ^¹³C NMR (75 MHz, CDCl₃): δ = 7.3, 17.1, 21.6, 28.0, 30.6, 33.5, 75.5, 79.9, 109.5. Anal. Calcd for C₉H₁₆O₂: C, 69.19; H, 10.32. Found: C, 69.27; H, 10.41.